<?xml version="1.0" encoding="UTF-8"?>
<response>

<lst name="responseHeader">
  <int name="status">0</int>
  <int name="QTime">12</int>
  <lst name="params">
    <str name="echoParams">explicit</str>
    <str name="indent">true</str>
    <str name="file">data-lines/./reut2-007.sgm-939.txt</str>
    <str name="usePOS">true</str>
    <str name="sentences">3</str>
    <str name="wt">xml</str>
    <str name="formula">augNorm_inverse</str>
  </lst>
</lst>
<lst name="analysis">
  <lst name="summary">
    <lst name="stats">
      <lst name="sentences">
        <int name="count">16</int>
      </lst>
      <lst name="terms">
        <int name="count">78</int>
      </lst>
      <lst name="stems">
        <int name="count">51</int>
      </lst>
    </lst>
    <lst name="terms">
      <lst name="term">
        <str name="text">marketing</str>
        <double name="strength">1.0</double>
      </lst>
      <lst name="term">
        <str name="text">months</str>
        <double name="strength">0.9999999999999992</double>
      </lst>
      <lst name="term">
        <str name="text">investigation</str>
        <double name="strength">0.9999999999999992</double>
      </lst>
      <lst name="term">
        <str name="text">subcommittee</str>
        <double name="strength">0.9999999999999992</double>
      </lst>
      <lst name="term">
        <str name="text">diseases</str>
        <double name="strength">0.999999999999999</double>
      </lst>
    </lst>
    <lst name="sentences">
      <lst name="sentence">
        <str name="text">ICN has been the focus of consirable investor attention in recent months because of Virazole, which has undergone clinical trials as a possible treatment of some AIDS-related diseases.</str>
        <int name="index">9</int>
        <int name="start">1</int>
        <int name="end">185</int>
        <double name="strength">1.0</double>
        <int name="terms">13</int>
      </lst>
      <lst name="sentence">
        <str name="text">The company has said its possible applications include treatment of some types of hepatitis, herpes, influenza, childhood diseases and hemorrhagic fevers.</str>
        <int name="index">8</int>
        <int name="start">1</int>
        <int name="end">155</int>
        <double name="strength">0.9587488260811854</double>
        <int name="terms">12</int>
      </lst>
      <lst name="sentence">
        <str name="text">Discussing the possibility of an acquisition, Panic said the such a purchase is necessary because ICN's current marketing capability would not be sufficient to support distribution of the company's products, given ICN's expectations for market growth worldwide.</str>
        <int name="index">5</int>
        <int name="start">1</int>
        <int name="end">262</int>
        <double name="strength">0.8291240620210182</double>
        <int name="terms">16</int>
      </lst>
    </lst>
    <lst name="highlighted">
      <lst name="sentence">
        <str name="text">ICN has been the &lt;em&gt;focus&lt;/em&gt; of &lt;em&gt;consirable investor attention&lt;/em&gt; in &lt;em&gt;recent months&lt;/em&gt; because of &lt;em&gt;Virazole,&lt;/em&gt; which has &lt;em&gt;undergone clinical trials&lt;/em&gt; as a &lt;em&gt;possible treatment&lt;/em&gt; of some AIDS-related &lt;em&gt;diseases&lt;/em&gt;.</str>
        <int name="index">9</int>
      </lst>
      <lst name="sentence">
        <str name="text">The &lt;em&gt;company&lt;/em&gt; has said its &lt;em&gt;possible applications include treatment&lt;/em&gt; of some &lt;em&gt;types&lt;/em&gt; of &lt;em&gt;hepatitis, herpes,&lt;/em&gt; influenza, &lt;em&gt;childhood diseases&lt;/em&gt; and &lt;em&gt;hemorrhagic fevers&lt;/em&gt;.</str>
        <int name="index">8</int>
      </lst>
      <lst name="sentence">
        <str name="text">Discussing the &lt;em&gt;possibility&lt;/em&gt; of an &lt;em&gt;acquisition, Panic&lt;/em&gt; said the such a &lt;em&gt;purchase&lt;/em&gt; is &lt;em&gt;necessary&lt;/em&gt; because ICN's &lt;em&gt;current marketing capability&lt;/em&gt; would not be &lt;em&gt;sufficient&lt;/em&gt; to &lt;em&gt;support distribution&lt;/em&gt; of the &lt;em&gt;company&lt;/em&gt;'s &lt;em&gt;products,&lt;/em&gt; given ICN's &lt;em&gt;expectations&lt;/em&gt; for &lt;em&gt;market growth worldwide&lt;/em&gt;.</str>
        <int name="index">5</int>
      </lst>
    </lst>
  </lst>
</lst>
</response>
